UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Pathway Financial Advisors LLC

Pathway Financial Advisors LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 18.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,092 shares of the healthcare conglomerate’s stock after selling 239 shares during the quarter. Pathway Financial Advisors LLC’s holdings in UnitedHealth Group were worth $638,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Rockingstone Advisors LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $291,000. Hoxton Planning & Management LLC lifted its holdings in UnitedHealth Group by 30.8% in the third quarter. Hoxton Planning & Management LLC now owns 1,512 shares of the healthcare conglomerate’s stock valued at $884,000 after acquiring an additional 356 shares during the last quarter. Brookstone Capital Management lifted its holdings in UnitedHealth Group by 6.7% in the third quarter. Brookstone Capital Management now owns 24,289 shares of the healthcare conglomerate’s stock valued at $14,201,000 after acquiring an additional 1,529 shares during the last quarter. Sugarloaf Wealth Management LLC lifted its holdings in UnitedHealth Group by 1.3% in the third quarter. Sugarloaf Wealth Management LLC now owns 6,764 shares of the healthcare conglomerate’s stock valued at $3,955,000 after acquiring an additional 90 shares during the last quarter. Finally, Park Place Capital Corp lifted its holdings in UnitedHealth Group by 4.2% in the third quarter. Park Place Capital Corp now owns 4,428 shares of the healthcare conglomerate’s stock valued at $2,589,000 after acquiring an additional 177 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $581.56 on Wednesday. The business’s fifty day moving average price is $582.58 and its 200 day moving average price is $528.49. The firm has a market capitalization of $537.02 billion, a PE ratio of 35.55, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the company posted $6.14 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.44%. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on UNH shares. Barclays upped their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Tuesday, October 1st. HSBC upped their price target on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price target for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Finally, Morgan Stanley upped their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.